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Abstract 
Herbal medicines are recognized as an effective treatment of common diseases, mainly 
associated with oxidative stress. Therefore developing drug delivery systems of these biological 
active ingredients are gaining interest. Parsley (Petroselinum crispum L.) is a well-known 
culinary herb and its leaf contains high amount of apigenin, therefore it is suitable as a natural 
source of this flavonoid. Apigenin possess many health effects such as antioxidant, anti-
inflammatory and anticancer activities. Unfortunately, these benefits are limited due to the low 
water solubility and bioavailability, it was recently classified as BCS II. group compound. 
Therefore the aim of this study was to develop a carrier system for Petroselinum crispum 
extract, containing high amount of apigenin. Microcrystalline cellulose inert pellet cores were 
chosen and enteric coatings were applied. The produced multiparticulates had spherical shape, 
narrow size distribution and low moisture content. 10 % (w/w) Eudragit
®
 L 30 D-55 and 15% 
(w/w) Eudragit
®
 FS 30 D coating was adequate for the modified release in vitro. The layered 
pellets demonstrated antioxidant activity. It was concluded that development of oral site-
specific pellets containing flavonoid extract successfull and the therapeutic effectiveness could 
be hypothesized. 
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1. INTRODUCTION 
Nowadays, drug delivery of phytochemicals has gained popularity due to their 
therapeutic effectiveness with low risk of side effects. Based on epidemiological and 
intervention studies, herbal medicines are recognized as an effective treatment of common 
diseases (Rashid et al., 2013). However, their effectiveness depends on the amount consumed 
and bioavailability of these materials (Manach et al., 2004). It is well known that the 
therapeutic outcome are the result of the synergistic effect of the compounds which is in 
correlation with genotype and growing conditions (Briskin, 2000). Therefore incorporation of 
these biological active ingredients could be beneficial in preventing or treating diseases, mainly 
associated with oxidative stress.  
Parsley (Petroselinum crispum L) is a well-known culinary herb in Europe and globally 
used in the human diet. Petroselini folium and fructus (leaf and seeds) are applied as herbal 
medicine since ancient times. This plant exhibit many biological activities like antioxidant 
(Zhang et al., 2006), antibacterial (Fejes et al.; 2000, Wang et al., 2006), anticoagulant (Gadi et 
al., 2009), anti-hyperlipidimic (Yazicioglu et al., 1996) and anti-hyperglycemic (Yanardag et 
al., 2003) properties. The essential oil in the seeds possess diuretic, antispasmodic and 
appetizer effect due to phenylpropene components (apiol and myristicin) (Racz et al., 1984). 
The leaf contains several compounds with health effects, including cancer prevention. This can 
be mainly attributed to flavonoids, a diverse group of phenolic compounds (Birt et al., 2001). It 
was proved that diet rich in polyphenols could decrease the risk of cardiovascular, neurological 
disorders and certain cancer. The majority of the consumed flavonoids are in glycosidic form (a 
sugar component is attached to the aglycon molecule) and possibly reach unaffected the 
duodenum. They are further hydrolyzed by ß -glucosidase enzymes which can enhance their 
absorption and antioxidant activity (Hostetler et al, 2012; Papay et al., 2014). In the parsley 
leaf, apigenin and its glycosides (apiin, apigetrin) are the main flavonoids therefore it is suitable 
as a natural source of apigenin (Merken et al., 2000; USDA Database, 2014) (Figure 1.).  
Several studies are published about the potential health effects of apigenin, such as antioxidant 
(Škerget et al., 2005) and anti-inflammatory activities (Choi et al., 2014). It is also able to 
induce apoptosis by modulating molecular signaling pathways on different cancer cell lines (Hu 
et al., 2008; Ren et al., 2011). Moreover, it has synergistic effect with paclitaxel (Xu et al., 
2011). In human colon cancer cell lines, apigenin is able to enhance the activities of anti-
metastatic protein, arrest the cell cycle and induce apoptosis (Chung et al., 2007; Lee et al., 
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2014; Lefort et al., 2011; Murthy et al., 2012; Shao et al., 2013). It was reported that after oral 
consumption of parsley leaves apigenin aglycon is able to absorb through the whole intestine, 
possibly with active and passive transport mechanisms, like other flavonoids (Meyer et al., 
2006; Nielsen et al., 1999). This indicates that the glycosides are also hydrolyzed by human ß-
glucosidase in the small intestine and bacterial ß -glucosidase enzyme in the colon (Berrin et 
al., 2003; Day et al., 1998; Hollman et al., 1996). Nevertheless, apigenin was recently classified 
as a BCS (Biopharmaceutical Classification System) class II compound due to its high 
permeability but low solubility (Zhang et al., 2012). Importantly, the bioavailability is 
influenced also by the food matrix and the microbial flora (Birt et al., 2001). 
Development of optimal delivery system could be challenging due to the diverse group 
and low solubility of compounds or the lack of knowledge about the exact dose. Orally 
administered multiple unit preparations such as pellets offer several advantages over single unit 
systems eg. matrix tablet. When pellets are taken orally, small particles spread uniformly 
initially in the stomach which reduce the gastric transit time, the irritation of gastric mucosa 
and the gastrointestinal transit could be more predictable and reproducible. With better 
distribution of multiparticulates in the intestine, bioavailability could be improved, moreover, 
inter- and intra-individual variations and food-effect could be avoided. While the total drug 
content is split into many units the damage of the coating or the failure of some units do not 
result dose dumping or the failure of the drug delivery system, resulting a reduction in side 
effects (Abdul et al., 2010; Varum et al., 2010). They are ideal to control and modify the drug 
release with polymeric film coatings (Lippold, 1997; Michael et al., 2008). Various resultant 
drug release profiles can be obtained by simply mixing pellets with different coatings 
(Bodmeier, 1997; Kallai et al., 2010) Specific coatings are able to control the release of the 
active ingredient as well as modulate the absorption from the gastrointestinal tract or to provide 
targeted delivery e.g. by colon targeting. The function of pH sensitive polymers are based on 
the pH differences in the gastrointestinal tract. Besides the physiological environment several 
factors are influencing the fate of dosage forms and therefore the bioavailability of the drugs 
after administration. For example, the viscosity of colonic luminal contents and the colonic 
enzymes are also contributing (Amidon et al., 2015).  
Only a few study reported previously the incorporation of plant material into 
multiparticulates. One prepared pellets with the mixture of Thymus vulgaris, Salvia officinalis 
and Urtica dioica dry extracts and investigated the dissolution profiles of different coating 
levels of Eudragit
®
 FS 30 (Kaledaite et al., 2014). In another study chitosan pellets were loaded 
with rutin to treat inflammatory bowel disease (Rabišková et al., 2012) and sustained release 
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pellets were prepared to increase the short half life of naringenin (Wang et al., 2013). The 
objective of our study was to develop a carrier system for Petroselinum crispum extract 
therefore enhance the apigenin intake with the synergistic effect of compounds, reduce the risk 
of diseases associated with oxidative stress and colon cancer. Pellets as a multiparticulate 
dosage form are optimal in this developmental phase due to the lack of knowledge about the 
exact dose and toxicity. Eudragit
® 
L 30 coated pellets allow targeted delivery to the small 
intestine thus increase the concentration therefore bioavailability of apigenin at the site of 
absorption. Furthermore, colon targeting therefore tumor supression could be achieved with 
Eudragit
®
 FS 30 coated cores. The produced pellets were further characterized and antioxidant 
activity measurement was also conducted to monitor the radical scavenging activity.  
2. MATERIALS AND METHODS 
2.1. Materials 
The commercially available dried parsley leaves (Kotányi Hungária Kft., Hungary) 
were purchased in the local grocery store (Budapest, Hungary). Microcrystalline cellulose inert 
pellets in the size range of 500-710 µm (MCC, Ethispheres

 600, NPPharm Ltd., France) and 
hydroxypropyl methylcellulose (HPMC, Pharmacoat

 606, Shin-Etsu Chemical Ltd., Japan) as 
a binder material for the layering process were chosen. The extrcat-layered pellets were further 
coated with 30 % (w/w) aqueous dispersion of Eudragit
® 
L 30 D-55 and Eudragit
®
 FS 30 D 
(Evonik Industries AG, Germany) enteric polymers. The additives were triethyl citrate (TEC) 
as a plasticizer (Fluka Chemie AG, Switzerland) and micronized talc as an antisticking agent 
(Sigma–Aldrich Ltd., Germany). Apigenin and its glycoside standards, 2,2-Diphenyl-1-
picrylhydrazyl (DPPH*) free radical, 37% , w/w hydrochloric acid, ammonium acetate, 
acetonitrile, ethanol (EtOH) and methanol (MeOH) were purchased from Sigma Aldrich 
(Sigma–Aldrich Ltd., Germany). The water was purified by using Milli-Q water system 
(Millipore, Germany) for HPLC-UV and HPLC-MS measurements.  
2.2.  Preparation of Petroselinum crispum extract 
Dried parsley leaves were milled with Retch Mixer Mill MM 400 (Germany) at 25 1/s 
frequency with 10 pieces of 1 cm diameter balls for 4 min. The particle parameters of D10, D50 
and D90 of the analyzed samples were estimated by laser diffraction (Malvern Mastersizer 
2000, Malvern Industries, Germany). The extraction procedure was carried out using same 
solid-to-solvent ratio as described previously (Justesen, 2000; Luthria et al., 2006). Under 
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constant stirring (500 rpm, ARE Heating magnetic stirrer, VELP Scientifica, Italy) by using 
50:50 (%, v/v) ethanol:water mixture as the extraction solvent. To optimize the duration and the 
temperature of the extraction procedure the apigenin content was measured every 15 minutes at 
25 
o
C, 40 
o
C, 60 
o
C, 80 
o
C for 2 hours. The samples were hydrolyzed to break the glycosodic 
bond and determine the total apigenin (aglycon) content (Liu et al., 2008). 1 ml of samples 
were filtered (20 µM pore Sartorius filter, Sartorius AG, Germany) and hydrolyzed for 1 hour 
at 90 
o
C with 0.5 ml 37% HCl prior to the further analysis. The efficacy of the hydrolysis was 
verified by mass spectrometer and the total apigenin content was measured by HPLC-UV 
method. To ensure that the apigenin remain stable during hydrolysis, 37% HCl was added to 
apigenin stock solution for 1 hour at 90 
o
C and controlled again with LC-MS method. All of the 
prepared extracts were stored in the fridge (4
 o
C) before use. The 3D figure of the results was 
plotted by using Origin 2015 software (OriginLab Corporation, USA).   
2.3.  Analytical Conditions   
The measurement of apigenin content was performed on Agilent 1100 Series HPLC 
equipped with diode array detector. A Supelco C18 (Sigma–Aldrich Ltd., Germany), 15cm x 
4.6 mm, particle size 3 µm column was employed for the separation. The column temperature 
was set to 25 °C. The isocratic mobile phase consisted of acetonitrile and 0.1 M ammonium 
acetate in 40:60 (w/w %) ratio. The flow rate was 0.8 mL/min, injection volume was 20 µL. 
The spectral data were recorded at 340 nm for 7 minutes (tR apigenin=6.2 min). The obtained 
chromatograms were evaluated with HP Agilent ChemStation program.  
For LC-MS analysis, the same column and settings were applied as described 
previously. The measurements were performed on 1290 Agilent HPLC/6460 triple quadrupole 
mass spectrometer (Agilent Technologies Inc., USA) with MassHunter Workstation program. 
Mass spectra were acquired in the negative ion mode using jet stream electrospray ion source 
which was 300°C. The instrument was set to scan from 60-800 Da mass range with 135 V 
fragmenter voltage. The identification of apigenin and its glycosides was achieved by 
comparison to literature data and standard solutions. All standards were prepared as stock 
solutions at 0.1 mg/mL in methanol, working standards were made by diluting stock solutions. 
The solutions were stored at 4 
o
C.  
2.4. Preparation of Active Ingredient-Layered and Coated Pellets 
2.4.1. Layering Process 
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The optimized extraction procedure was performed to achieve a parsley extract with 
high apigenin content. Thereafter the ethanol from the obtained extract was evaporated under 
vacuum at 60 °C (Büchi Rotavapor R-200, Büchi Labortechnik AG, Switzerland). The aqueous 
extract was further lyophilized (Finn-Aqua Lyovac GT3, Germany) and redissolved in aqueous 
HPMC solution (Pharmacoat
®
 606; 2.0 % w/w) and layered onto the inert cores with in a 
centrifuged bottom spray configured fluidized bed apparatus (Aeromatic Strea I, Aeromatic-
Fielder AG, Switzerland) to achieve 6 mg apigenin content. During the layering process, the 
dispersion was stirred continuously at room temperature.  
 
2.4.2. Enteric Coating of Active Ingredient-Layered Pellets 
The P. crispum extract layered cores were divided into two parts: the first part was 
coated with Eudragit
®
 L 30 D-55 and the second part with Eudragit
®
 FS 30 D using the same 
fluid bed apparatus described previously. The concentration of film forming polymer in the 
coating suspension was 25.8 % w/w. TEC (10%, w/w on dry Eudragit
®
 L 30 or 5 %, w/w on 
dry Eudragit
®
 FS 30) and micronized talc (< 10 µm, 50% w/w on dry polymer) were used. 
During the coating process in order to prevent the sedimentation of the talc, the suspensions 
were stirred continuously. A series of film coated herbal extract loaded pellets were produced 
with different polymer film thicknesses and quantified by the weight gain (5% w/w; 10% w/w 
and 15% w/w). The preparation procedure was the same at both cases. The optimized layering 
and coating conditions for the preparation of pellets in fluid bed process parameters can be seen 
on Table I.  
2.5. Characterization methods 
2.5.1. Determination of Apigenin Content  
The total apigenin content of uncoated pellet formulations was evaluated over 
accurately measured 1.000 g pellets. The herbal extraction containing layer was dissolved in 
purified water and the volume was made up to the mark. The total apigenin concentrations were 
determined after hydrolysis with the above mentioned HPLC-MS and HPLC-UV method. 
2.5.2. Physical Properties of the Pellets 
Shape and size. The uncoated and coated pellets were characterized using Retch 
Camsizer
®
 Dynamic Image Analyzer apparatus (V.4.2.1., Haan, Germany). Approximately 4 g 
of pellets of each batches was poured into the hopper of the instrument. The sample was then 
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dropped in front of the measuring cameras to record particle size and shape. The measuring 
range was between 30 µm-30 mm.  
Near Infrared Spectroscopy, NIR. All scans were performed by Hitachi U-3501 
UV/VIS/NIR spectrophotometer equipped with integrating sphere (d = 60 mm) and PbS 
detector. (Hitachi, Japan). MCC cores, layered and coated pellets containing different 
proportions of Eudragit
®
 L 30 (5, 10, and 15 %) were randomly chosen and scanned on both 
faces using NIR spectroscopy. The reflectance was recorded in the range of 800-2500 nm 
wavelength using a 5 mm layered cell. Samples were scanned at 2 nm intervals with 600 
nm/min speed. The data analysis were performed by using UV Solutions computer program 
(Hitachi, Japan). 
Fourier-Transform Infrared Spectroscopy, FT-IR. FT-IR spectra of layered and coated 
pellets were evaluated using a Bruker Optics ALPHA FT-IR spectrometer (Bruker Corporation, 
USA) in the frequency range between 4000-400 cm
-1
 and with a spectral resolution of 4 cm
-1
. 
The data were analyzed using the Opus 7.5 software (Bruker Corporation). 
 Scanning Electron Microscopy Analysis, SEM. Structure of the cross sectioned P. 
crispum extract loaded pellet, coated with Eudragit
®
 FS 30 were placed on the sample holder 
using double adhesive tape and gold coating was applied. Examinations were performed by 
means of a scanning electron microscope (FEI Inspect
TM
 S50, USA) at 20.00 kV accelerating 
voltage. Working distance was between 16 and 21 mm. Original magnification was 50-150x 
with accuracy of ± 2%.  
Densities and flowability properties. The bulk and tapped densities of the pellets were 
determined by using a tapvolumeter (STAV 2003 Stampfvolumeter, Germany). 50 g material 
was poured into a 250 mL graduated glass cylinder and tapped 1250 times (n=3). The occupied 
volume by the material was read precisely. The bulk (ρbulk) and tapped (ρtapped) density, as well 
as the compressibility were calculated using the values of ρbulk and ρtapped according to Eq.1. 
 
 
The ratio of the ρtapped to ρbulk provide the Hausner ratio Eq. 2. (Chatlapalli et al., 1998):     
 
 
                    
               
     
               [1] 
   
       
     
                [2]      
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The flowability of the pellets was measured by a flowtime and cone-angle testing instrument 
(PharmaTest Ptg, Germany) with an 8 mm orifice. The flow rate was calculated by dividing the 
bead weight (50 g) by the flow time. The measurements were made in triplicate. 
Crushing strength. Twenty pellets of each batch were measured with texture analyzer 
(TexturePro CT3, Brookfield Engineering Labs, Inc., USA) opearting with 4500 g load cell. 
The pellets were manually placed onto a lower flat platen, centered under the 4 mm diameter 
cylindrical upper punch operating with a speed of 0.05 mm/s. The force-time graphs were 
recorded using the texture analyzer pc software (TexturePro CT V1.4). The crushing load (F) 
and the diameter (d) of each individual pellet were recorded. The crushing strength (σ, the force 
needed to break the pellets) was calculated from the crushing force (F) and the pellet diameter 
(d) using Eq. 3. (Cespi et al., 2007). The first peak was recorded as a breaking load. The 
average crushing strentgh of 20 values is shown on Table III.  
 
 
 
Loss on drying. The moisture content of the pellets were measured as a loss of weight 
using infrared dryer (Precisa XM 60 HR, Precisa Gravimetrics AG, Switzerland). A 0.20 g 
sample was heated up to 70
o
C until the loss in weight was not more than 0.50%. The evaluation 
was done in triplicates and the standard deviation was calculated. 
2.5.3. Dissolution studies 
The dissolution studies were carried out using the USP basket method with 100 rpm at 
37± 0.5 °C in 900 mL. Hanson SR8-Plus
TM
 Dissolution Test Station (Hanson Research, USA) 
apparatus were used. The dissolution test for 1.00 g uncoated and coated pellets was carried out 
in triplicates. At predetermined time points, 1 mL filtered samples were withdrawn. The 
medium was kept at a constant volume by refilling it with fresh buffer solution. The 
concentration of the released total apigenin was measured by the above described HPLC-UV 
method. The quantifications were based on standards, the hydrolysis was monitored with 
HPLC-MS.  
To determine the apigenin release from uncoated pellets the dissolution test (n=3) was carried 
out using three media with pH 1.0 (HCl buffer), pH 6.8 and pH 7.2 (phosphate buffer) for 5 
minutes.  
Eudragit
®
 L 30 coated pellets were exposed to pH 1.0 solution for 2 hours thereafter to pH 6.8 
phosphate buffer for 1 hour.  
  
     
    
                 [3] 
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After exposing to acidic media the Eudragit
®
 FS 30 coated cores for 2 hours, pH 6.8 buffer for 
3 hours and pH 7.2 buffers for 1 hour were used. 
2.5.4. Antioxidant activity 
The antioxidant activity of the prepared pellets were compared to apigenin solution and 
plant extract in order to investigate the effectiveness of the formulation. The free radical 
scavenging activity of the cores were measured by using DPPH* free radical with deep purple 
color and a characteristic absorbance peak at 517 nm. It is a simple, inexpensive and 
comparable method, however, it is sensitive to pH and interfere with polymers (Sharma et al., 
2009) therefore only the uncoated pellets were compared. Briefly, methanolic stock solution of 
0.1 mM DPPH* reagent was freshly prepared and protected from light until further use. 
Standard curve was plotted between the DPPH* concentration and absorbance and the linear 
relationship was calculated graphically (R
2
>0.999). For sample preparation, the 1.00 g layered 
cores were dissolved in 100 mL methanol.  
Similarly, 100 mL methanol was added to 1 g of MCC core and 2% HPMC dispersion to 
ensure that excipients do not interfere with DPPH*.  
0.1 mL of sample and 0.9 mL methanol were added to 2 mL of 0.06 mM DPPH* methanolic 
solution. Thereafter vortex mixed for 10 s and protected from light. The absorbance at 517 nm 
was determined with spectrophotometer (UV-Vis spectrophotometer, Metertech SP-8001, 
Metertech Inc., Taiwan) in until the steady state (60 minutes). The addition of samples resulted 
decrease in the absorbance due to the scavenging activity of the oxidisable groups of apigenin 
and other antioxidants. The standard curve was used to calculate the exact concentration of the 
free radical. The antioxidant activity was expressed as percentage of the inhibition of DPPH* in 
the solution. The more DPPH* are inhibited, the stronger the antioxidant is. All measurements 
carried out three times and the data were expressed as the mean value ± SD. 
3. RESULTS AND DISCUSSION 
3.1. Preparation of Petroselinum crispum extract 
The extractability of the apigenin with its glycosides in different solvents and the most 
effective extraction procedures were described previously by Luthria et al. (Luthria et al., 2006; 
Luthria et al., 2008). Therefore stirring was chosen at higher temperature with 50:50 (%, v/v) 
solvent mixture and to obtain higher apigenin level dried parsley leaves were finely milled to 
achieve around 200 µm (D50) particle size. The typical solid-to-solvent ratio was 40 ml/g. To 
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ensure higher apigenin concentration the optimum extraction conditions were estimated to be at 
60 
o
C for 90 minutes as shown on Figure 2. The total content of apigenin (aglycon and 
glycosides) range between 1.7 – 13.5 g in 100 g dried parsley leaves (spice), with a mean value 
of 4.5 g (USDA Database, 2014) which was in accordance with our data. It is well known that 
the plant phenolic content is highly affected by genotype, growing and processing conditions 
(Mišan et al., 2011).  
 The analytical methods were optimized to determine the total aglycon content in the 
herbal extract. Acidic hydrolysis was necessary to break the glycoside bonds of apiin and 
apigetrin glycosides (Figure 1.) (Liu et al., 2008). The effectiveness of the hydrolysis was 
verified by HPLC-MS analysis. Deprotonated molecular mass ([M-H
-
]) was selected due to the 
acidic nature of flavonoids (Justesen, 2000; Plazonic et al., 2009). Mass spectra of extract and 
hydrolyzed extract can be seen on Figure 3 A and B. On the mass spectrum of plant extract the 
product ion of main apigenin glycoside can be identified, namely apiin ([M-H
-
] = 563). On the 
spectrum of hydrolyzed extract only the aglycon, apigenin, ([M-H
-
] = 269) could be observed. 
Presence of apigenin was further verified with the detection of the following fragments: 117, 
151, 197 and 201 m/z.  It was concluded that the hydrolysis was proved to be complete with the 
applied conditions. 
3.2. Characterization of the Pellets 
3.2.1. Apigenin Content  
The apigenin content of the pellet formulation was evaluated. The average apigenin load 
was measured to be 96.5 % of theoretical loading for P. crispum extract layered cores. The 
appointed apigenin content could be achieved with the layering process. It is known that health 
benefits of polyphenols depend on the amount consumed and the bioavailability, which is 
influenced by the food matrix and the consumer’s microbial flora (Birt et al., 2001). Daily 
intake of flavonoids, show high variability among countries and individuals. The daily apigenin 
is quite low, for example it was estimated to be 1 mg (Hertog et al., 1993) in The Netherlands 
and 3 ± 1 mg in European Union (Vogiatzoglou et al., 2015). This formulation make possible 
higher apigenin intake than consumption of the plant, moreover, the herbal extract contain 
other polyphenols allowing synergistic effect of the compounds. 
3.2.2. Shape, Size and SEM Analysis  
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Retch Camsizer
®
 instrument is able to detect simultaneously the particle size, shape and 
distribution due to the digital image processing. The produced herbal pellets are ideal for the 
coating process due to their narrow size distribution, regular round shape and smooth surface. 
The particle obtained size distribution (D10, D50, D90; mm) of uncoated and coated pellets are 
represented on Table II. The majority of the P. crispum layered cores lay within the interval 
0.6-0.7 mm. In each case, the size is increasing with increasing polymer content (5, 10, 15 %, 
w/w), as expected (Figure 4.).  
Spherical shape is an important product quality requirement. The sphericity of the 
particles were considered to be adequate, close to the inert core ~1. The herbal extract layered 
multiparticulates are less spherical, probably due to the small amount of associated plant 
material. Sphericity data are represented on Table III.  
Scanning electron microscopic image of a coated cross-section pellet was applied to 
investigate the structure of the inner part of the pellets. The P. crispum extract layer and 
polymer can be observed (Figure 5.). The size of the particle correlates well with the above 
mentioned data.  
3.2.3. NIR and FT-IR analyses 
NIR spectroscopy is a non-destructive and fast analytical technique therefore commonly 
applied in the pharmaceutical industry. It is based on the absorbance of near-infrared light 
(780-2500 nm) due to molecular vibrations of H-bonds (Luypaert et al., 2007). The layering 
and coating process of inert cores with the herbal extract and with different levels of Eudragit
®
 
L 30 dispersions can be well monitored. The reflectance spectra are shown in Figure 6. It can 
be seen that as the polymer content is increasing, the diffuse reflectance of the pellets is 
decreasing due to the absorption of infrared light in the thicker layers. 
FT-IR is a spectroscopic analysis method based on the absorption of infra-red rays by 
molecular linkages and therefore allows a quick and efficient identification of the compounds 
by their functional groups and bond vibrations (Bunaciu et al., 2010). Figure 7. demonstrates 
the spectra of raw apigenin, parsley extract, layered and coated cores. In the FT-IR spectrum of 
raw apigenin, the characteristic vibrations are the following: 1450-1380 cm
-1 
C-H bend, 1730-
1680 cm
-1
 C=O stretch and 2710-2580 cm
-1
 O-H bond. The peaks of aromatic hydroxyl groups 
can be also observed at 3660-3200 cm
-1
 attributed to O-H stretching, bands at 1625-1585 and 
1520-1480 cm
-1
 (C-C stretch in ring) and 835-690 cm
-1
 (C-H bend ‘OOP’) assigned to the 
aromatic group (Figure 7.). Petroselinum crispum aqueous extract contained diverse materials. 
The main broad band at 3300 cm
-1 
indicating high water content, peaks at 1400-1600 cm
-1 
and 
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at 835-690 cm
-1 
suggesting the presence of aromatics, like apigenin and its glycosides.Bend 
3600-3100 cm
-1
 is assigned to O-H stretch in the spectrum of MCC, at 2900 cm
-1
 indicates C-H 
stretch and skeletal vibrations can be observed (C-C, C-O and C-OH) bands at 1310-1360 cm
-1
 
and around 1000 cm
-1
. In the spectrum of layered core, the C-H bend at 1470-1405 cm
-1
 and C-
H stretch at 300-2825 cm
-1
 and at 835-690 cm
-1 
suggesting also aromatic hydroxyl groups 
which is an indirect confirmation of the presence of plant material. Eudragit
®
 FS 30 polymer 
dispersion contains water therefore a broad band appear at 3300 cm
-1
. Peaks of C-H stretch and 
C-H bend could be also observed. The exhibited a high water content was not present in the 
spectrum of coated pellets as expected therefore film formation can be assumed. The polymer 
film layer did not hinder the penetration of infrared rays into the herbal layer therefore some 
characteristic peaks of aromatic hydroxyl groups could be seen (O-H stretch, C-C stretch in 
ring and C-H bend ‘OOP’). 
3.2.4. Densities and flowability properties, Crushing strength and Loss on drying 
 The layering and coating processes did not affect the good flowability properties 
of the starter core. Bulk and tapped densities as well as the derived parameters were calculated. 
The Hausner ratios of the pellets were around 1. The Carr’s compressibility index of each batch 
was estimated under 10. The angle of repose was calculated to be less than 25°.  
The mechanical properties of the inert MCC pellets showed ductile behavior, as 
expected (Cespi et al., 2007). The first peak on the graph indicates the first fracture on the 
surface of the pellet. The crushing strength of starter MCC core was lower than the layered and 
coated pellets. Different active substances might influence the crushing strength, pellets layered 
with P. crispum extract had higher value of crushing strength probably as the result of several 
compounds. However, there were no differences in the crushing strengths of the active 
ingredient layered pellets coating with Eudragit
®
 L 30 and Eudragit
®
 FS 30. In each case the 
Eudragit
®
 FS 30 coating has slightly increased the mechanical strength of the pellets compared 
to Eudragit
®
 L 30 coated cores. This can be attributed to flexibility of Eudragit
®
 FS 30. 
Eudragit
®
 L 30 polymer is quite brittle therefore not suitable as pellet coating for compression 
into tablets (Abraham et al., 2004; Nollenberger et al., 2013). The coating level has not affected 
significantly the crushing strength. Since the all of the key parameters were adequate, good 
packing into tablets or capsules can be assumed. 
The moisture content of all pellets was under 5 % (w/w). A slightly increase can be 
observed along with layering and coating processes. Considering the low moisture contents of 
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the pellets, the drying processes were adequate. All the above mentioned parameters are listed 
in Table III. 
3.3. Dissolution studies 
The apigenin release from the uncoated layered pellets was immediate and completed 
within 5 minutes in distilled water and each dissolution media (pH=1.0, pH=6.8, pH=7.2) due 
to the water soluble binder material (HPMC). The apigenin release was complete therefore the 
possible occlusion by the porous surface of MCC cores can be excluded (Rivera et al., 1994). 
We concluded that the water insoluble MCC inert core was suitable for the active ingredients.  
Eudragit
®
 L 30 and Eudragit
®
 FS 30 film coatings have great potential to control drug 
release and are available on the market as aqueous dispersion of the polymer. They are well 
known anionic copolymers of methacrylic acid with pH dependent solubility. They contain 
carboxyl groups which remain unionized in the acidic pH of the stomach and transformed to 
carboxylate groups when the pH increases thus dissolves above pH=5.5 and pH=7. The 
numbers of carboxyl groups influence the dissolution pH of the polymer which makes them 
suitable for enteric and ileo-colonic drug delivery (Nollenberger et al., 2013). Taking into 
consideration that the solubility has a major role in the dissolution, the polymer coating 
thickness is involved regulating the drug release pattern (Palugan et al., 2015). Therefore in this 
study the influence of coating thickness on apigenin release rate was investigated, ranging from 
5 to 15 % (w/w). Figure 8. demonstrates the release profile of the formulations. Loaded pellets 
coated with 5 % (w/w) Eudragit
®
 L 30 and FS 30 was not appropriate for enteric delivery due 
to the permeability to the acidic media due to poor polymer content (Gao et al., 2006). 
Sufficient acid-resistance was achieved when the coating level was 10% (w/w) Eudragit
®
 L 30 
and 15 % (w/w) Eudragit
®
 FS 30. Thereafter exposed to pH=6.8 media the Eudragit
®
 L 30 
coated cores, 70% apigenin release occured within 30 minutes. The increase in the pH of the 
dissolution fluid (pH=6.8) accelerates the rate of dissolution. In our study 10 % (w/w) polymer 
content was suitable for enteric coating with complete and ready release of active ingredient at 
pH= 6.8 within 1 hour, although the transit time of the pellets in the small intestine were 
reported to be 3 hours (Gupta et al., 2001). For colonic delivery neither the 5 % (w/w) nor the 
10 % (w/w) Eudragit
®
 FS 30 aqueous coated pellets were adequate. At 5 % (w/w) coating level 
approximately 30 % apigenin was released at pH=1.0 within 2 hours. In case of 10 % (w/w) 
coating, the apigenin release completed within 3 hours. Nevertheless at the highest polymer 
coating level, less than 10% release was detected at pH=6.8 for 3 hours. At pH=7.2, 40% 
release occurred within 30 minutes and total apigenin release within 1 hour. This result 
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correlates well with previously published data, 15 % (w/w) was suitable for colonic delivery of 
drugs (e.g.: 5-aminosalicylic acid) (Huyghebaert et al., 2005; Ibekwe et al., 2006; Rudolph et 
al., 2001). In comparison with herbal pellets coated with Eudragit
®
 FS 30, 20% of polymer 
coating was sufficient for the acid resistance and they also observed 40% drug release within 
30 minutes (Kaledaite et al., 2014).  However, the pH threshold of this polymer is a key factor, 
different threshold pH of Eudragit
®
 FS 30 were reported in the literature: pH=6.8 (Kaledaite et 
al., 2014; Gupta et al., 2001) and pH=7.5 (Rudolph et al., 2001) but the critical dissolution pH 
was proved to be pH=7.2 (Gao et al., 2006). Furthermore, different lag time (Tlag) was observed 
at pH=7.2 such as 20 min (Huyghebaert et al., 2005) and 30 min (Gao et al., 2006). We 
concluded from our data that more than 40% apigenin release occur after 30 minutes with 
Tlag=10 minutes at pH=7.2 and 15% (w/w) Eudragit
®
 FS 30 coating ensured the acid-resistance 
ability and the ileo-colonic delivery 
 
 
3.4. Antioxidant activity 
DPPH* is a widely used stable free radical to measure the antioxidant properties of 
natural compounds owing to reproducibility, comparability and easy to perform (Villaño et al., 
2007). Antioxidant activity measurements were conducted in order to investigate the 
scavenging activity of pellets. Figure 9. demonstrates the percentage of the inhibited DPPH* in 
the samples. The discoloration of the DPPH* radical indicating the scavenging activity of 
apigenin and other compounds in P. crispum extract. The more DPPH* inhibited, the stronger 
the antioxidant is. MCC and HPMC do not have radical scavenging activity and do not interfere 
with the free radical therefore no discoloration (no inhibition) was be observed. P. crispum 
extract proved to be stronger antioxidant than the methanolic solution of apigenin. This 
property is closely related to the position and the degree of hydroxylation and the hydrogen 
donating ability (Yang et al., 2008). Generally the aglycon molecule is stronger antioxidant 
than its glycosidic forms (Papay et al., 2014) but in this case the plant extract is stronger 
antioxidant due to several compounds than the methanolic solution only containing apigenin. 
The plant extract layered pellets possess also stronger activity than apigenin solution but less 
than P. crispum extract itself. This could be attributed to the loss of antioxidants with poor 
stability e.g. carotenoids and vitamins during the processes. It can be concluded that the main 
active ingredient and its biological activity could be formulated successfully and the therapeutic 
effectiveness is hypothesized. 
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4. CONCLUSION 
Herbal medicines are recognized as an effective and safe treatment of common diseases 
associated with oxidative stress and pharmaceutical pellets are proved to be a suitable dosage 
form for Petroselinum crispum extract. Eudragit
®
 L 30 and Eudragit
®
 FS 30 coated spheres 
could allow site-specific delivery to the main absorption site in order to increase the 
effectiveness, which should be further supported in vivo. The produced pellets have adequate 
physical properties, and the drug release is modulated. The in vitro antioxidant activity 
measurement verified that the scavenging activity is maintained.  
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Legend to Figures 
Figure 1. Structure of apigenin (R1or2=H), apiin (R1=apioglucoside) and apigetrin (R2=glucose) 
glucosides. 
Figure 2. 3D contour plot for the effects of duration and temperature of the extraction 
procedure. 
Figure 3. Mass spectra of raw (A) and hydrolyzed (B) P. crispum extracts.  
Figure 4. Cumulative particle size distribution curves and particle fractions of Eudragit L
®
 
15% (w/w) coated pellets. 
Figure 5. Magnified scanning electron microscopy photographs of a cross-sectioned pellet 
based on MCC. 
Figure 6. Overlaid raw (A) and 2nd D (B, magnified) NIR spectra of MCC, uncoated and 
coated pellets containing 5, 10, and 15% (w/w) Eudragit
®
 FS 30. 
Figure 7. FT-IR spectra of apigenin, plant extract layered and coated cores with Eudragit FS
®
 
30 15% (w/w).  
Figure 8. Release profiles of coated pellets with different coating levels (w/w): 5% 
(rhomboids), 10% (squares), 15% (triangles) for Eudragit
®
 L 30 (open symbols) and 
Eudragit
®
 FS 30 (filled symbols) type coating polymers, (n = 3, SD < 5%.). 
Figure 9. Radical scavenging activity of apigenin-layered pellets. The antioxidant activity is 
expressed as inhibition of DPPH* free radical in percent. 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
24 
 
 
Figure 1 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
25 
 
 
Figure 2 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
26 
 
 
Figure 3 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
27 
 
 
Figure 4 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
28 
 
 
Figure 5 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
29 
 
 
Figure 6 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
30 
 
 
Figure 7 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
31 
 
 
Figure 8 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
32 
 
 
Figure 9 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
33 
 
 
Table I.  Optimized Layering and Coating Conditions for the Preparation of Pellets. 
  
 
 
  
 Layering Coating 
Parameters 
 
Eudragit
®
 L 30  Eudragit
®
 FS 30 
Batch size (g) 300 150 150 
Spray nozzle diameter (mm) 1.2 1.2 1.2 
Inlet air temperature (°C) 45-47 39-41 28-31 
Outlet air temperature (°C) 35-39 34-36 25-26 
Atomizing pressure (bar) 0.8 0.8 0.8 
Fluid air flow rate (m
3
/h) 80-120 80-100 80-100 
Spray rate (g/min) 5-7 5-10 2-4 
Drying temperature (°C) 45 45 30 
Drying time (min) 15 15 15 
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Table II. Particle size distribution of layered and coated (%: coating level) pellets. Data were 
obtained by Retch Camsizer
®
 Dynamic Image Analyzer apparatus. The size is 
expressed in mm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
P. crispum extract 
P. crispum extract loaded, 
Eudragit
®
 L coated 
P. crispum extract loaded,  
Eudragit
®
 FS coated 
           loaded,  
          uncoated 5% 10% 15% 5% 10% 15% 
D 10 0.554 0.573 0.596 0.610 0.571 0.589 0.593 
D 50 0.624 0.648 0.679 0.693 0.654 0.670 0.683 
D 90 0.703 0.735 0.772 0.888 0.780 1.025 1.086 
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Table III. Physical Characteristics of the Layered and Coated Pellets (Mean ± SD). 
 
  
Parameters Inert core 
P. extract 
layered 
Eudragit
®
 L 
coated 
Eudragit
®
 FS 
coated 
Bulk density (g/cm
3
) 0.81 ± 0.001 0.91 ± 0.001 0.84 ± 0.002 0.92 ± 0.003 
Tapped density (g/cm
3
) 0.86 ± 0.002 0.93 ± 0.003 0.86 ± 0.001 0.96 ± 0.001 
Hausner ratio (HR) 1.06 1.02 1.01 1.04 
Carr’s index (CI, %) 6.17 2.19 2.38  4.34 
Flow time (s) 4.2 4.8 5.7 5.2 
Angle of repose (°) 18 19.1 22.7 21.8 
Loss on drying (%) 1.90 ± 0.38 2.56 ± 0.09 2.60 ± 0.09 2.49 ± 0.26 
Crushing strength 
(n=20) (N/mm
2
) 
4.96 ± 0.49 5.22 ± 0.43 5.32 ± 0.82 5.49 ± 0.75 
Sphericity 1.00 ± 0.002 0.904 ± 0.10 0.938 ± 0.019 0.941 ± 0.013 
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